ahlam1399
07-11-2016, 08:55 PM
UPDATE 3-**vartis copy of Amgen arthritis drug highly similar -FDA staff
July 11 (Reuters) - **vartis AG's cheaper versio**f Amgen Inc's blockbuster arthritis drug Enbrel ishighly similar in potency and safety to the original, accordingto a review by Food and Drug Administration staff.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=AK7WwZNrCKQ:HmdCnMn-fH0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=AK7WwZNrCKQ:HmdCnMn-fH0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=AK7WwZNrCKQ:HmdCnMn-fH0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=AK7WwZNrCKQ:HmdCnMn-fH0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=AK7WwZNrCKQ:HmdCnMn-fH0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/AK7WwZNrCKQ
July 11 (Reuters) - **vartis AG's cheaper versio**f Amgen Inc's blockbuster arthritis drug Enbrel ishighly similar in potency and safety to the original, accordingto a review by Food and Drug Administration staff.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=AK7WwZNrCKQ:HmdCnMn-fH0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=AK7WwZNrCKQ:HmdCnMn-fH0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=AK7WwZNrCKQ:HmdCnMn-fH0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=AK7WwZNrCKQ:HmdCnMn-fH0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=AK7WwZNrCKQ:HmdCnMn-fH0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/AK7WwZNrCKQ